A recent study from Harvard University suggests that the use of GLP-1 weight loss medications may be associated with significant improvements in women's social and economic standing, including increased chances of marriage, cohabitation, and employment. The research, led by Harvard economics professor Rebecca Diamond, analyzed data from the Understanding America Study, a panel survey conducted by the University of Southern California.

The study compared women who began using GLP-1 drugs for weight loss with a control group of women who intended to start but had not yet begun treatment. The analysis considered factors such as body mass, health status, income, employment, partnership status, and overall well-being prior to treatment.

Researchers focused on women, who are more likely to use these medications for weight loss than men, and excluded individuals using GLP-1s for diabetes management. The findings indicated that women who achieved weight loss through these medications experienced notable changes in their life outcomes over approximately 18 months.

Specifically, marriage and cohabitation rates increased by 29% among single women. For women who were not employed at the study's outset, employment prospects rose by 27%. However, no clear upward trend in career progression was observed for those who were already employed.

Diamond posited that these results suggest a portion of the "female obesity penalty" stems from societal judgments in social and professional matching processes. This perspective is supported by commentary from Dr. Peter Balazs, a hormone and weight loss specialist not involved in the study. Balazs noted that the effects were most apparent in situations involving new matches, such as job interviews or dating, rather than within existing relationships or jobs, suggesting societal bias plays a role.

Patients often report increased confidence and feeling more "visible" after losing weight, which could positively influence performance in interviews and networking. Balazs also pointed to potential hormonal and metabolic benefits contributing to psychological relief, which may further open opportunities.

However, despite the observed improvements in relationships and employment, the study found no significant increase in reported life satisfaction, depression, or loneliness among the women who lost weight. Dr. Krishna Vyas, a plastic surgeon, commented that while patients often feel more confident after weight loss and may "re-engage with life," the lack of reported increase in overall well-being suggests that external societal perceptions, rather than internal feelings, were primarily affected.

The study acknowledged potential limitations, including its observational nature, which means it can only show associations and not definitive cause-and-effect relationships. The findings are also considered preliminary as the paper has not yet undergone peer review. Furthermore, the study's focus solely on women could introduce bias, and the reliance on self-reported data is another limitation. Researchers were also unable to ascertain if those who found new jobs were earning more money, and the disconnect between external gains and internal satisfaction raises questions about the true impact on overall well-being.